Home
Amerise Biosciences Ltd PE Ratio

Amerise Biosciences Ltd
NSE: AMERISEBIOSCIE
PE
Key Highlights
- The P/E Ratio of Amerise Biosciences Ltd is 0 as of 22 Feb 12:13 PM .
- The P/E Ratio of Amerise Biosciences Ltd changed from 17 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
- The Latest Trading Price of Amerise Biosciences Ltd is ₹ 0.89 as of 21 Feb 15:30 .
- The PE Ratio of Finance Industry has changed from 11.0 to 17.8 in 5 years. This represents a CAGR of 10.10%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Amerise Biosciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Amerise Biosciences Ltd
Company Fundamentals for Amerise Biosciences Ltd

Amerise Biosciences Ltd
NSE: AMERISEBIOSCIE
Share Price
Market Price of Amerise Biosciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 0.89 |
20 Feb 2025 | 0.92 |
19 Feb 2025 | 0.88 |
18 Feb 2025 | 0.87 |
17 Feb 2025 | 0.88 |
14 Feb 2025 | 0.9 |
13 Feb 2025 | 0.89 |
12 Feb 2025 | 0.91 |
11 Feb 2025 | 0.94 |
10 Feb 2025 | 0.98 |
BlinkX Score for Amerise Biosciences Ltd
Asset Value vs Market Value of Amerise Biosciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Amerise Biosciences Ltd | 5.88 | - |
Bajaj Finance Ltd | 520466 | 32.6 |
Bajaj Finserv Ltd | 299925 | 35.0 |
Jio Financial Services Ltd | 148476 | 92.4 |
Bajaj Holdings & Investment Ltd | 135979 | 18.1 |
Company | |
---|---|
Amerise Biosciences Ltd | 5.88 |
Bajaj Finance Ltd | 520466 |
Bajaj Finserv Ltd | 299925 |
Jio Financial Services Ltd | 148476 |
Bajaj Holdings & Investment Ltd | 135979 |
PE Ratio of Amerise Biosciences Ltd Explained
₹5.88
Market cap
₹0
Earnings
0.0X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Finance Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Amerise Biosciences Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Amerise Biosciences Ltd
Historical Revenue, EBITDA and Net Profit of Amerise Biosciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Amerise Biosciences Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Amerise Biosciences Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Amerise Biosciences Ltd
About Amerise Biosciences Ltd
- Amerise Biosciences Limited (Formerly known Amradeep Industries Limited) was incorporated in 1984 by a private Indian party, as a specialized manufacturer of high quality construction equipment and agricultural equipment.
- On October 29, 2002 the name of the Company was changed from Amstar Laminates Limited to Amardeep Industries Limited and further to Amerise Biosciences Limited in August, 2021.
- Initially, the Company was engaged into the business of commodity trading. During the financial year 2007 it entered into the trading of castor seeds.
- As of now the Company is not engaged in any activity and the management is looking for a right opportunity to make the Company operational.
- Due to scarcity of working capital funds, the Company is not able to perform any business activities.
Amerise Biosciences Ltd News Hub
Amerise Biosciences reports standalone net loss of Rs 0.05 crore in the June 2024 quarter
Net Loss of Amerise Biosciences reported to Rs 0.05 crore in the quarter ended June 2024 as against
Read more
06 Aug 24
Amerise Biosciences schedules AGM
Amerise Biosciences announced that the Annual General Meeting (AGM) of the company will be held on 3
Read more
18 Sept 24
Amerise Biosciences schedules board meeting
Amerise Biosciences will hold a meeting of the Board of Directors of the Company on 22 October 2024.
Read more
17 Oct 24
Amerise Biosciences reports standalone net loss of Rs 0.03 crore in the September 2024 quarter
Net Loss of Amerise Biosciences reported to Rs 0.03 crore in the quarter ended September 2024 as aga
Read more
22 Oct 24